Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Type (2017–2030)
7.3. Market Revenue, by Application (2017–2030)
7.4. Market Revenue, by End user (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Type (2017–2030)
8.3. Market Revenue, by Application (2017–2030)
8.4. Market Revenue, by End user (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Type (2017–2030)
9.3. Market Revenue, by Application (2017–2030)
9.4. Market Revenue, by End user (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Type (2017–2030)
10.3. Market Revenue, by Application (2017–2030)
10.4. Market Revenue, by End user (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Type (2017–2030)
11.3. Market Revenue, by Application (2017–2030)
11.4. Market Revenue, by End user (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Type (2017–2030)
12.3. Market Revenue, by Application (2017–2030)
12.4. Market Revenue, by End user (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Type (2017–2030)
13.3. Market Revenue, by Application (2017–2030)
13.4. Market Revenue, by End user (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Type (2017–2030)
14.3. Market Revenue, by Application (2017–2030)
14.4. Market Revenue, by End user (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Type (2017–2030)
15.3. Market Revenue, by Application (2017–2030)
15.4. Market Revenue, by End user (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Type (2017–2030)
16.3. Market Revenue, by Application (2017–2030)
16.4. Market Revenue, by End user (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Type (2017–2030)
17.3. Market Revenue, by Application (2017–2030)
17.4. Market Revenue, by End user (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Type (2017–2030)
18.3. Market Revenue, by Application (2017–2030)
18.4. Market Revenue, by End user (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Type (2017–2030)
19.3. Market Revenue, by Application (2017–2030)
19.4. Market Revenue, by End user (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Type (2017–2030)
20.3. Market Revenue, by Application (2017–2030)
20.4. Market Revenue, by End user (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Type (2017–2030)
21.3. Market Revenue, by Application (2017–2030)
21.4. Market Revenue, by End user (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Type (2017–2030)
22.3. Market Revenue, by Application (2017–2030)
22.4. Market Revenue, by End user (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Type (2017–2030)
23.3. Market Revenue, by Application (2017–2030)
23.4. Market Revenue, by End user (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Type (2017–2030)
24.3. Market Revenue, by Application (2017–2030)
24.4. Market Revenue, by End user (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Type (2017–2030)
25.3. Market Revenue, by Application (2017–2030)
25.4. Market Revenue, by End user (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Type (2017–2030)
26.3. Market Revenue, by Application (2017–2030)
26.4. Market Revenue, by End user (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Type (2017–2030)
27.3. Market Revenue, by Application (2017–2030)
27.4. Market Revenue, by End user (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Type (2017–2030)
28.3. Market Revenue, by Application (2017–2030)
28.4. Market Revenue, by End user (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Type (2017–2030)
29.3. Market Revenue, by Application (2017–2030)
29.4. Market Revenue, by End user (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. MIMEDX Group, Inc
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. VIVEX Biologics, Inc
31.2.1. Business overview
31.2.2. Product and service offerings
31.3. Organogenesis Holdings Inc
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Integra Lifesciences Holdings Corporation
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Stryker Corporation
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Applied Biologics
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Celularity Inc
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. Skye Biologics Holdings, LLC
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Lucina BioSciences, LLC
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. Next Biosciences
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. TissueTech, Inc
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. Corza Ophthalmology
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Merakris Therapeutics, Inc
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Ventris Medical, LLC
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Tides Medical
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 羊膜製品とは、羊膜から得られる生物学的素材を利用した製品であり、主に医療分野で注目されています。羊膜は、胎児の発育を支えるための膜であり、栄養や酸素を供給し、外部からの傷や感染から胎児を保護する役割を果たしています。この特性を生かして、羊膜製品はさまざまな治療や手術に利用されています。 羊膜製品にはいくつかの種類があります。代表的なものとしては、羊膜片、羊膜を用いたドレッシング、羊膜の抽出物などがあります。羊膜片は、主に傷や潰瘍の治療に使用され、細胞の再生を助ける働きがあります。特に、火傷や外傷性の傷の治癒を促進するために用いられ、優れた抗炎症作用や抗菌作用を示します。 羊膜製品の用途は多岐にわたります。皮膚再生医療や眼科手術、整形外科、歯科などにおいて、傷の治癒を促進するために利用されています。皮膚の再生を助けるためのコラーゲンや成長因子を豊富に含んでいるため、特に慢性創傷や糖尿病性潰瘍の治療に効果が期待されています。また、眼科分野では、角膜移植や眼瞼下垂の治療にも使用されることがあります。 さらに、羊膜製品は、骨の再生や修復を助けるための治療にも応用されています。整形外科の分野では、骨折や関節の損傷に対する治療として、羊膜から抽出された成分が使用され、骨の癒合を促進するために役立っています。しばしば、人工骨材と組み合わせて使用されることがあります。 羊膜製品の関連技術は多様化しており、製品開発においても進展が見られます。羊膜を加工するための最新の技術には、冷凍保存技術や乾燥技術、化学的処理技術などが含まれます。これにより、羊膜の特性を最大限に活かし、医療における利用価値を向上させることが可能となっています。 また、羊膜製品は倫理的な側面にも配慮されています。多くの羊膜製品は、出産時に不要となった羊膜を原材料として利用しており、安全性や倫理的な問題に関しても一定の基準が設けられています。これにより、医療現場での活用が進む一方で、倫理的な批判を回避することができています。 これまでの研究や臨床試験により、羊膜製品は効果的な治療手段としての実績を重ねてきました。今後も研究が進むことで、新たな応用や技術革新が期待されており、さらに多くの疾患へのアプローチが模索されるでしょう。 羊膜製品は、再生医療や傷の治療において重要な役割を果たす可能性を秘めた素材であり、今後の医療分野の発展に寄与することが期待されています。その特性を最大限に活かし、新たな治療法や製品が継続的に開発され、患者の生活の質を向上させることにつながるでしょう。羊膜製品は、医療技術の進歩とともに進化していく分野であり、今後の研究への注目が高まります。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

